| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adrian Rawcliffe | Director | 2026-08-12 | 12,700 | $5.29 | $67.18kSell |
| Aik Na Tan | Director | 2026-08-11 | 432 | $6.01 | $2.60kSell |
| Heidi L. Wagner | Director | 2026-08-11 | 7,000 | $5.97 | $41.79kBuy |
| Heidi L. Wagner | Director | 2026-08-11 | 7,000 | $6.01 | $42.07kSell |
| Ken Takanashi | Director | 2026-08-11 | 3,864 | $6.01 | $23.22kSell |
| Ra Capital Management LP | Director | 2026-03-30 | 971,091 | $6.50 | $6.31MBuy |
| Ra Capital Management LP | Director | 2026-03-27 | 2,495,623 | $6.43 | $16.05MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 4,954,558 | $6.06 | $30.02MBuy |
| Ra Capital Management LP | Director | 2026-03-26 | 351,224 | $6.38 | $2.24MBuy |
| Chris Francis | SVP Corporate Development Head of Emerging Areas | 2026-02-26 | 15,294 | $4.75 | $72.65kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gsk PLC | 14.68% | 28,929,452 | $140.60M | Insider |
| Ken Takanashi | 9.76% | 19,232,895 | $93.47M | Insider |
| Ra Capital Management LP | 3.86% | 7,602,428 | $36.95M | Insider |
| Masaharu Tanaka | 1.41% | 2,774,118 | $13.48M | Insider |
| Chandra Vargeese | 0.21% | 408,246 | $1.98M | Insider |
| Paul Bolno | 0.14% | 275,520 | $1.34M | Insider |
| Gregory L. Verdine | 0.14% | 275,217 | $1.34M | Insider |
| Kyle Moran | 0.07% | 134,385 | $653.11k | Insider |
| Michael A. Panzara | 0.06% | 109,103 | $530.24k | Insider |
| Takeshi Wada | 0.05% | 100,635 | $489.09k | Insider |